LivaNova Builds Strategic Base And Commercial Case To Silence Skeptics

Medical innovator LivaNova has a new stated focus: it won’t go outside the head and the heart when it comes to potential M&A and technology development projects. It has set out short- and longer-term solutions to boost sales and/or profitability in its neuromodulation and cardio franchises. What is certain is that eight months into his tenure as CEO, Damien McDonald is stamping his imprint all over LivaNova.

livanova

LivaNova PLC’s twin-continent Investor Day road show in September was an illustration of how far the UK-registered company has come in a short time. And how much it has changed under the leadership of former Danaher executive Damien McDonald. With the backing of a supportive board, McDonald, whose CV includes a range of top medtech jobs in a 25-year industry career, has put in place strategic business and key staff changes that are designed to give a strong sense of certainty to health-care sector stakeholders and shareholders.

“Certainty” is a big word in the McDonald corporate vocabulary, as analysts and investors at the London leg of the...

More from Growth

More from In Vivo